docetaxel anhydrous has been researched along with cx 5461 in 1 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (cx 5461) | Trials (cx 5461) | Recent Studies (post-2010) (cx 5461) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 84 | 1 | 83 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, HH; Chen, Y; Chiu, YC; Gorthi, A; Huang, Y; Wang, LJ; Zhang, S; Zhang, T | 1 |
1 other study(ies) available for docetaxel anhydrous and cx 5461
| Article | Year |
|---|---|
Predicting drug response of tumors from integrated genomic profiles by deep neural networks.
Topics: Antineoplastic Agents; Benzothiazoles; Cell Line, Tumor; Deep Learning; Docetaxel; Genomics; Humans; Mutation; Naphthyridines; Transcriptome | 2019 |